Re: Consulting Agreement Dear Mr. Lytle:Actuate Therapeutics, Inc. • May 24th, 2024 • Pharmaceutical preparations • Delaware
Company FiledMay 24th, 2024 Industry JurisdictionYou and Actuate Therapeutics, Inc. (the “Company”) have had discussions concerning your desire to render professional consulting services to the Company as described herein. The Company wants to engage your services, and you want to render them, subject to the terms and conditions of this letter agreement (this “Agreement”), which shall become effective upon the last date of signature of this Agreement by both parties (the “Effective Date”). For the purpose of this Agreement, you shall be referred to herein as “Consultant.”
Re: Consulting Agreement Dear Mr. Lytle:Actuate Therapeutics, Inc. • March 4th, 2024 • Services-commercial physical & biological research • Delaware
Company FiledMarch 4th, 2024 Industry JurisdictionYou and Actuate Therapeutics, Inc. (the “Company”) have had discussions concerning your desire to render professional consulting services to the Company as described herein. The Company wants to engage your services, and you want to render them, subject to the terms and conditions of this letter agreement (this “Agreement”), which shall become effective upon the last date of signature of this Agreement by both parties (the “Effective Date”). For the purpose of this Agreement, you shall be referred to herein as “Consultant.”